These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Dalen JE; Alpert JS; Hirsh J Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222 [No Abstract] [Full Text] [Related]
31. Thrombolytic treatment of acute pulmonary embolism in myotonic dystrophy. Jabr FI J Emerg Med; 2006 Feb; 30(2):220-1. PubMed ID: 16567263 [No Abstract] [Full Text] [Related]
32. [Comment on "Fibrinolysis for patients with intermediate-risk pulmonary embolism"]. Castro Mda G Rev Port Cardiol; 2014 Oct; 33(10):663-4. PubMed ID: 25594091 [No Abstract] [Full Text] [Related]
36. Thrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor. Han S; Chaya C; Hoo GW J Intensive Care Med; 2006; 21(4):240-5. PubMed ID: 16855059 [TBL] [Abstract][Full Text] [Related]
37. In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke. Akl EA; Guyatt GH Ann Intern Med; 2014 Sep; 161(6):JC8-9. PubMed ID: 25222420 [No Abstract] [Full Text] [Related]